awgldk
/
wikidata
/
Login
Register
TriplyDB
Wikidata
Browser
Table
SPARQL
Graphs
1
1
Services
1
1
Assets
0
0
Insights
Schema
BETA
Class frequency
Class hierarchy
Q38931732-02EC14C7-922E-428C-BD8F-9183EC2588C4
Q38931732-02EC14C7-922E-428C-BD8F-9183EC2588C4
BestRank
Statement
http://www.wikidata.org/entity/statement/Q38931732-02EC14C7-922E-428C-BD8F-9183EC2588C4
Re-examining HSPC1 inhibitors.
P2860
Q38931732-02EC14C7-922E-428C-BD8F-9183EC2588C4
BestRank
Statement
http://www.wikidata.org/entity/statement/Q38931732-02EC14C7-922E-428C-BD8F-9183EC2588C4
rank
NormalRank
type
BestRank
Statement
wasDerivedFrom
afe3d564166118dfdc70034e420115340b15b98c
P2860
Acquired resistance to 17-allylamino-17-demethoxygeldanamycin (17-AAG, tanespimycin) in glioblastoma cells.